Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.

NCT07679412 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

CMV Retinitis

Interventions

BIOLOGICAL: LB-DTK-CMV

Sponsor

LucasBio